mutLBSgeneDB
mutLBSgeneDB
mutated Ligand Binding Site gene DataBase
|
Gene summary |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
Cancer type specific mutLBS sorted by frequency |
LBS | AAchange of nsSNV | Cancer type | # samples |
K84 | T82N | COAD | 1 | Y319 | S320L | SKCM | 1 | H117 | I116F | SKCM | 1 | H304 | H304Y | SKCM | 1 | Y317 | P315S | SKCM | 1 | L128 | E126D | STAD | 1 | W227 | W227L | UCEC | 1 |
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma. |
Relative protein structure stability change (ΔΔE) using Mupro 1.1 Mupro score denotes assessment of the effect of mutations on thermodynamic stability. (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability) |
: nsSNV at non-LBS: nsSNV at LBS |
nsSNVs sorted by the relative stability change of protein structure by each mutation Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene. |
LBS | AAchange of nsSNV | Relative stability change |
H117 | I116F | -1.3559497 | H304 | H304Y | -1.1057686 | K84 | T82N | -0.76558605 | Y317 | P315S | -0.74446362 | L128 | E126D | -0.6654193 | W227 | W227L | -0.49132846 | Y319 | S320L | -0.455769 |
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132) |
Structure image for AKR1C3 from PDB |
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types |
Differential co-expressed gene network based on protein-protein interaction data (CePIN) |
Gene level disease information (DisGeNet) |
Disease ID | Disease name | # PubMed | Association type |
umls:C0032460 | Polycystic Ovary Syndrome | 6 | Biomarker, GeneticVariation |
umls:C0014175 | Endometriosis | 2 | Biomarker |
umls:C0028754 | Obesity | 2 | Biomarker |
umls:C0033578 | Prostatic Neoplasms | 2 | Biomarker |
umls:C0014170 | Endometrial Neoplasms | 1 | AlteredExpression, Biomarker |
umls:C0007621 | Cell Transformation, Neoplastic | 1 | Biomarker |
umls:C0038356 | Stomach Neoplasms | 1 | Biomarker |
Allele ID | AA change | Clinical significance | Origin | Phenotype IDs |
Gene expression profile of anticancer drug treated cell-lines (CCLE) Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient. |
Gene-centered drug-gene interaction network |
Drug information targeting mutLBSgene (Approved drugs only) |
Drug status | DrugBank ID | Name | Type | Drug structure |
Nutraceutical | DB00157 | NADH | Small molecule | |
Approved|investigational | DB00905 | Bimatoprost | Small molecule | |
Experimental|illicit | DB01536 | 4-Androstenedione | Small molecule | |
Experimental | DB01698 | Rutin | Small molecule | |
Experimental | DB02056 | (5e,13e)-9,15-Dihydroxy-11-Oxoprosta-5,13-Dien-1-Oicacid | Small molecule | |
Experimental | DB02266 | Flufenamic Acid | Small molecule | |
Experimental | DB03461 | 2'-Monophosphoadenosine 5'-Diphosphoribose | Small molecule | |
Experimental | DB07700 | 3-CARBOXAMIDO-1,3,5(10)-ESTRATRIEN-17(R)-SPIRO-2'(5',5'-DIMETHYL-6'OXO)TETRAHYDROPYRAN | Small molecule | |
Gene-centered ligand-gene interaction network |
Ligands binding to mutated ligand binding site of AKR1C3 go to BioLip |
Ligand ID | Ligand short name | Ligand long name | PDB ID | PDB name | mutLBS |
NDP | | NADPH | 1ry8 | B | H117 | ACT | | ACETATE | 1s1p | A | H117 | NAP | | NADP ZWITTERION | 1s1p | A | H117 | ACT | | ACETATE | 1s1r | A | H117 | NAP | | NADP ZWITTERION | 1s1r | A | H117 | NAP | | NADP ZWITTERION | 1s2a | A | H117 | NAP | | NADP ZWITTERION | 1s2c | A | H117 | NAP | | NADP ZWITTERION | 1xf0 | A | H117 | NAP | | NADP ZWITTERION | 1zq5 | A | H117 | NAP | | NADP ZWITTERION | 2f38 | A | H117 | NAP | | NADP ZWITTERION | 2fgb | A | H117 | NAP | | NADP ZWITTERION | 3r43 | A | H117 | NAP | | NADP ZWITTERION | 3r6i | A | H117 | NAP | | NADP ZWITTERION | 3r7m | A | H117 | IZP | | LEVIBUPROFEN | 3r8g | A | H117 | NAP | | NADP ZWITTERION | 3r8h | A | H117 | NAP | | NADP ZWITTERION | 3r94 | A | H117 | NAP | | NADP ZWITTERION | 3ug8 | A | H117 | NAP | | NADP ZWITTERION | 3ugr | A | H117 | NAP | | NADP ZWITTERION | 3uwe | A | H117 | NAP | | NADP ZWITTERION | 4dbs | A | H117 | NAP | | NADP ZWITTERION | 4dbw | A | H117 | NAP | | NADP ZWITTERION | 4dbw | B | H117 | NAP | | NADP ZWITTERION | 4dz5 | A | H117 | NAP | | NADP ZWITTERION | 4fa3 | A | H117 | NAP | | NADP ZWITTERION | 4fal | A | H117 | NAP | | NADP ZWITTERION | 4fam | A | H117 | NAP | | NADP ZWITTERION | 4fam | B | H117 | NAP | | NADP ZWITTERION | 4h7c | A | H117 | NAP | | NADP ZWITTERION | 4hmn | A | H117 | NAP | | NADP ZWITTERION | 4wrh | A | H117 | YY1 | | 5-METHYL-4H-1,2,4-TRIAZOLE-3-THIOL | 4wrh | A | H117 | NAP | | NADP ZWITTERION | 4wdt | A | H117 | NAP | | NADP ZWITTERION | 4wdu | A | H117 | WDW | | 3,6-DIHYDROPYRIDIN-1(2H)-YL(5-METHYL-1H-INDOL-2-YL) METHANONE | 4wdw | A | H117 | NAP | | NADP ZWITTERION | 4wdx | A | H117 | NAP | | NADP ZWITTERION | 4wdx | B | H117 | NAP | | NADP ZWITTERION | 4xve | A | H117 | NAP | | NADP ZWITTERION | 4yvv | A | H117 | NAP | | NADP ZWITTERION | 4yvv | B | H117 | NAP | | NADP ZWITTERION | 4yvx | A | H117 | NAP | | NADP ZWITTERION | 4yvx | B | H117 | 0HV | | 3-[(4-NITRONAPHTHALEN-1-YL)AMINO]BENZOIC ACID | 4dbs | B | H117 L128 W227 | PG2 | | PROSTAGLANDIN D2 | 1ry0 | A | H117 L128 W227 Y319 | RUT | | RUTIN | 1ry8 | A | H117 W227 | IMN | | INDOMETHACIN | 1s2a | A | H117 W227 | FLF | | FLUFENAMIC ACID | 1s2c | A | H117 W227 | ID8 | | MEFENAMIC ACID | 3r43 | A | H117 W227 | JMS | | MECLOFENAMATE | 3r6i | A | H117 W227 | SUZ | | SULINDAC | 3r7m | A | H117 W227 | IMN | | INDOMETHACIN | 3ugr | A | H117 W227 | VJJ | | 3-PHENOXYBENZOIC ACID | 3uwe | A | H117 W227 | 0HV | | 3-[(4-NITRONAPHTHALEN-1-YL)AMINO]BENZOIC ACID | 4dbs | A | H117 W227 | BT9 | | 3-{[4-(TRIFLUOROMETHYL)PHENYL]AMINO}BENZOIC ACID | 4dbu | A | H117 W227 | 0SZ | | 3-(3,4-DIHYDROISOQUINOLIN-2(1H)-YLSULFONYL)BENZOIC ACID | 4fam | A | H117 W227 | 0SZ | | 3-(3,4-DIHYDROISOQUINOLIN-2(1H)-YLSULFONYL)BENZOIC ACID | 4fam | B | H117 W227 | WDT | | 2-NITRO-5-(PHENYLSULFONYL)PHENOL | 4wdt | A | H117 W227 | WDW | | 3,6-DIHYDROPYRIDIN-1(2H)-YL(5-METHYL-1H-INDOL-2-YL) METHANONE | 4wdw | B | H117 W227 | WDX | | [4-(2-HYDROXYETHYL)PIPERIDIN-1-YL](5-METHYL-1H-INDOL-2- YL)METHANONE | 4wdx | A | H117 W227 | WDX | | [4-(2-HYDROXYETHYL)PIPERIDIN-1-YL](5-METHYL-1H-INDOL-2- YL)METHANONE | 4wdx | B | H117 W227 | GBM | GLIBENCLAMIDE | 5-CHLORO-N-(2-{4-[(CYCLOHEXYLCARBAMOYL) SULFAMOYL]PHENYL}ETHYL)-2-METHOXYBENZAMIDE | 4yvv | A | H117 W227 | GBM | GLIBENCLAMIDE | 5-CHLORO-N-(2-{4-[(CYCLOHEXYLCARBAMOYL) SULFAMOYL]PHENYL}ETHYL)-2-METHOXYBENZAMIDE | 4yvv | B | H117 W227 | GMR | GLIMEPIRIDE | 3-ETHYL-4-METHYL-N-[2-(4-{[(CIS-4-METHYLCYCLOHEXYL) CARBAMOYL]SULFAMOYL}PHENYL)ETHYL]-2-OXO-2,5-DIHYDRO- 1H-PYRROLE-1-CARBOXAMIDE | 4yvx | A | H117 W227 | GMR | GLIMEPIRIDE | 3-ETHYL-4-METHYL-N-[2-(4-{[(CIS-4-METHYLCYCLOHEXYL) CARBAMOYL]SULFAMOYL}PHENYL)ETHYL]-2-OXO-2,5-DIHYDRO- 1H-PYRROLE-1-CARBOXAMIDE | 4yvx | B | H117 W227 | GCZ | GLICLAZIDE | N-[(3AR,6AS)-HEXAHYDROCYCLOPENTA[C]PYRROL-2(1H)- YLCARBAMOYL]-4-METHYLBENZENESULFONAMIDE | 4zfc | A | H117 W227 | GCZ | GLICLAZIDE | N-[(3AR,6AS)-HEXAHYDROCYCLOPENTA[C]PYRROL-2(1H)- YLCARBAMOYL]-4-METHYLBENZENESULFONAMIDE | 4zfc | B | H117 W227 | RUT | | RUTIN | 1ry8 | B | H117 W227 H304 Y319 | PG2 | | PROSTAGLANDIN D2 | 1ry0 | B | H117 W227 Y317 Y319 | ZOM | | ZOMEPIRAC | 3r8h | A | H117 W227 Y317 Y319 | 0T0 | | 3-(3,4-DIHYDROISOQUINOLIN-2(1H)-YLSULFONYL)-N- METHYLBENZAMIDE | 4fal | A | H117 W227 Y317 Y319 | WDV | | 4-NITRO-2-({4-[3-(TRIFLUOROMETHYL)PHENYL]PIPERAZIN-1- YL}METHYL)PHENOL | 4xvd | A | H117 W227 Y317 Y319 | WDV | | 4-NITRO-2-({4-[3-(TRIFLUOROMETHYL)PHENYL]PIPERAZIN-1- YL}METHYL)PHENOL | 4xvd | B | H117 W227 Y317 Y319 | FLR | | R-FORM | 3r94 | A | H117 W227 Y319 | NPX | | (R) -NAPROXEN SODIUM SALT | 3ufy | A | H117 W227 Y319 | 0HV | | 3-[(4-NITRONAPHTHALEN-1-YL)AMINO]BENZOIC ACID | 4dbs | A | H117 W227 Y319 | 0HV | | 3-[(4-NITRONAPHTHALEN-1-YL)AMINO]BENZOIC ACID | 4dbs | B | H117 W227 Y319 | BT9 | | 3-{[4-(TRIFLUOROMETHYL)PHENYL]AMINO}BENZOIC ACID | 4dbu | B | H117 W227 Y319 | 511 | 2'-DESMETHYL-INDOMETHACIN | [1-(4-CHLOROBENZOYL)-5-METHOXY-1H-INDOL-3-YL]ACETIC ACID | 4dbw | A | H117 W227 Y319 | 511 | 2'-DESMETHYL-INDOMETHACIN | [1-(4-CHLOROBENZOYL)-5-METHOXY-1H-INDOL-3-YL]ACETIC ACID | 4dbw | B | H117 W227 Y319 | 0SL | | (3R)-1-(NAPHTHALEN-2-YLSULFONYL)PIPERIDINE-3-CARBOXYLIC ACID | 4fa3 | A | H117 W227 Y319 | 16J | | [4-(4-CHLOROPHENYL)PIPERAZIN-1-YL](MORPHOLIN-4-YL) METHANONE | 4hmn | A | H117 W227 Y319 | WDU | | 4-CHLORO-N-(4-CHLOROBENZYL)-5-NITRO-1H-PYRAZOLE-3- CARBOXAMIDE | 4wdu | A | H117 W227 Y319 | IMN | | INDOMETHACIN | 3ug8 | A | H117 Y317 Y319 | NPS | | NAPROXEN | 3r58 | A | H117 Y319 | NAP | | NADP ZWITTERION | 1ry0 | A | K84 H117 | NAP | | NADP ZWITTERION | 1ry0 | B | K84 H117 | NDP | | NADPH | 1ry8 | A | K84 H117 | NAP | | NADP ZWITTERION | 3r58 | A | K84 H117 | NAP | | NADP ZWITTERION | 3r8g | A | K84 H117 | NAP | | NADP ZWITTERION | 3ufy | A | K84 H117 | NAP | | NADP ZWITTERION | 4dbs | B | K84 H117 | NAP | | NADP ZWITTERION | 4dbu | B | K84 H117 | NAP | | NADP ZWITTERION | 4wdw | A | K84 H117 | NAP | | NADP ZWITTERION | 4wdw | B | K84 H117 | NAP | | NADP ZWITTERION | 4xvd | A | K84 H117 | NAP | | NADP ZWITTERION | 4xvd | B | K84 H117 | NAP | | NADP ZWITTERION | 4zfc | A | K84 H117 | NAP | | NADP ZWITTERION | 4zfc | B | K84 H117 | 511 | 2'-DESMETHYL-INDOMETHACIN | [1-(4-CHLOROBENZOYL)-5-METHOXY-1H-INDOL-3-YL]ACETIC ACID | 4dbw | B | L128 W227 | 511 | 2'-DESMETHYL-INDOMETHACIN | [1-(4-CHLOROBENZOYL)-5-METHOXY-1H-INDOL-3-YL]ACETIC ACID | 4dbw | A | W227 | E04 | | 3-CARBOXAMIDO-1,3,5(10)-ESTRATRIEN-17(R)-SPIRO-2'(5',5'-DIMETHYL-6'OXO)TETRAHYDROPYRAN | 1zq5 | A | W227 Y317 Y319 | 10H | | 1-(4-{[(2R)-2-METHYLPIPERIDIN-1-YL]SULFONYL}PHENYL)-1, 3-DIHYDRO-2H-PYRROL-2-ONE | 4h7c | A | W227 Y317 Y319 | WDS | | 3-PENTYL-2-[(PYRIDIN-2-YLMETHYL)SULFANYL]-7- (PYRROLIDIN-1-YLCARBONYL)QUINAZOLIN-4(3H)-ONE | 4xve | A | W227 Y317 Y319 | ASD | | ANDROST-4-ENE-3,17-DIONE | 1xf0 | A | W227 Y319 | 15M | | BIMATOPROST | 2f38 | A | W227 Y319 | P6G | | HEXAETHYLENE GLYCOL | 2fgb | A | W227 Y319 |
Multiple alignments for P42330 in multiple species |
LBS | AA sequence | # species | Species |
A218 | LVAYGALGTQR | 2 | Mus musculus, Rattus norvegicus | A218 | LVAYSALGSQR | 1 | Homo sapiens | A253 | YKRTPALIALR | 2 | Mus musculus, Rattus norvegicus | A253 | HKRTPALIALR | 1 | Homo sapiens | A269 | GVVVLAKSYNE | 1 | Homo sapiens | A269 | GIVALAKSFNE | 1 | Mus musculus | A269 | GIVTLVKSFNE | 1 | Rattus norvegicus | C7 | DSKHQCVKLND | 1 | Homo sapiens | C7 | NSKIQKIELND | 1 | Mus musculus | C7 | NSKIQKMELND | 1 | Rattus norvegicus | D224 | LGTQRYKYCIN | 2 | Mus musculus, Rattus norvegicus | D224 | LGSQRDKRWVD | 1 | Homo sapiens | D50 | GFRHIDSAHLY | 1 | Homo sapiens | D50 | GFCHIDCSHLY | 1 | Mus musculus | D50 | GFRHIDCSHLY | 1 | Rattus norvegicus | E192 | VCNQVECHLYL | 2 | Mus musculus, Rattus norvegicus | E192 | VCNQVECHPYF | 1 | Homo sapiens | F15 | LNDGHSIPVLG | 2 | Mus musculus, Rattus norvegicus | F15 | LNDGHFMPVLG | 1 | Homo sapiens | F284 | QNVQVFEFQLT | 1 | Homo sapiens | F284 | ENMQVFDFQLA | 1 | Mus musculus | F284 | ENLQVFDFQLA | 1 | Rattus norvegicus | F306 | RNLHYFNSDSF | 1 | Homo sapiens | F306 | RNLRYFPADMF | 1 | Mus musculus | F306 | RNLRYFPANMF | 1 | Rattus norvegicus | F311 | FNSDSFASHPN | 1 | Homo sapiens | F311 | FPADMFKAHPN | 1 | Mus musculus | F311 | FPANMFKAHPN | 1 | Rattus norvegicus | G22 | PVLGFGTYATE | 2 | Mus musculus, Rattus norvegicus | G22 | PVLGFGTYAPP | 1 | Homo sapiens | G220 | AYGALGTQRYK | 2 | Mus musculus, Rattus norvegicus | G220 | AYSALGSQRDK | 1 | Homo sapiens | G264 | YQLQRGVVVLA | 1 | Homo sapiens | G264 | YQLDRGIVALA | 1 | Mus musculus | G264 | YQLERGIVTLV | 1 | Rattus norvegicus | H117 | DLYLIHFPVSL | 2 | Mus musculus, Rattus norvegicus | H117 | DLYLIHSPMSL | 1 | Homo sapiens | H304 | LDRNLHYFNSD | 1 | Homo sapiens | H304 | LDRNLRYFPAD | 1 | Mus musculus | H304 | LDRNLRYFPAN | 1 | Rattus norvegicus | K270 | VVVLAKSYNEQ | 1 | Homo sapiens | K270 | IVALAKSFNEE | 1 | Mus musculus | K270 | IVTLVKSFNEE | 1 | Rattus norvegicus | K84 | IFYTSKLWSTS | 2 | Mus musculus, Rattus norvegicus | K84 | IFYTSKLWSTF | 1 | Homo sapiens | L122 | HSPMSLKPGEE | 1 | Homo sapiens | L122 | HFPVSLKPGNE | 1 | Mus musculus | L122 | HFPVSLKPGDE | 1 | Rattus norvegicus | L128 | KPGEELSPTDE | 1 | Homo sapiens | L128 | KPGNELLPKDE | 1 | Mus musculus | L128 | KPGDELLPQDE | 1 | Rattus norvegicus | L219 | VAYGALGTQRY | 2 | Mus musculus, Rattus norvegicus | L219 | VAYSALGSQRD | 1 | Homo sapiens | L236 | NSPVLLEDPVL | 1 | Homo sapiens | L236 | DTPVLLDDPVL | 1 | Mus musculus | L236 | DTPVLLDDPIL | 1 | Rattus norvegicus | L261 | ALRYQLQRGVV | 1 | Homo sapiens | L261 | ALRYQLDRGIV | 1 | Mus musculus | L261 | ALRYQLERGIV | 1 | Rattus norvegicus | L268 | RGVVVLAKSYN | 1 | Homo sapiens | L268 | RGIVALAKSFN | 1 | Mus musculus | L268 | RGIVTLVKSFN | 1 | Rattus norvegicus | L54 | IDCSHLYQNEE | 2 | Mus musculus, Rattus norvegicus | L54 | IDSAHLYNNEE | 1 | Homo sapiens | M120 | LIHFPVSLKPG | 2 | Mus musculus, Rattus norvegicus | M120 | LIHSPMSLKPG | 1 | Homo sapiens | N167 | SIGVSNFNRRQ | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | N273 | LAKSYNEQRIR | 1 | Homo sapiens | N273 | LAKSFNEERIR | 1 | Mus musculus | N273 | LVKSFNEERIR | 1 | Rattus norvegicus | N280 | QRIRQNVQVFE | 1 | Homo sapiens | N280 | ERIRENMQVFD | 1 | Mus musculus | N280 | ERIRENLQVFD | 1 | Rattus norvegicus | N307 | NLHYFNSDSFA | 1 | Homo sapiens | N307 | NLRYFPADMFK | 1 | Mus musculus | N307 | NLRYFPANMFK | 1 | Rattus norvegicus | P318 | SHPNYPYSDEY | 1 | Homo sapiens | P318 | AHPNFPFFDEY | 1 | Mus musculus | P318 | AHPNFPFSDEY | 1 | Rattus norvegicus | Q190 | KPVCNQVECHP | 1 | Homo sapiens | Q190 | KPVCNQVECHL | 1 | Mus musculus | Q190 | RPVCNQVECHL | 1 | Rattus norvegicus | Q222 | GALGTQRYKYC | 2 | Mus musculus, Rattus norvegicus | Q222 | SALGSQRDKRW | 1 | Homo sapiens | Q279 | EQRIRQNVQVF | 1 | Homo sapiens | Q279 | EERIRENMQVF | 1 | Mus musculus | Q279 | EERIRENLQVF | 1 | Rattus norvegicus | Q6 | MDSKHQCVKLN | 1 | Homo sapiens | Q6 | MNSKIQKIELN | 1 | Mus musculus | Q6 | MNSKIQKMELN | 1 | Rattus norvegicus | R226 | TQRYKYCINED | 2 | Mus musculus, Rattus norvegicus | R226 | SQRDKRWVDPN | 1 | Homo sapiens | R276 | SYNEQRIRQNV | 1 | Homo sapiens | R276 | SFNEERIRENM | 1 | Mus musculus | R276 | SFNEERIRENL | 1 | Rattus norvegicus | S118 | LYLIHFPVSLK | 2 | Mus musculus, Rattus norvegicus | S118 | LYLIHSPMSLK | 1 | Homo sapiens | S129 | PGEELSPTDEN | 1 | Homo sapiens | S129 | PGNELLPKDEH | 1 | Mus musculus | S129 | PGDELLPQDEH | 1 | Rattus norvegicus | S166 | KSIGVSNFNRR | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | S217 | VLVAYGALGTQ | 2 | Mus musculus, Rattus norvegicus | S217 | VLVAYSALGSQ | 1 | Homo sapiens | S221 | YGALGTQRYKY | 2 | Mus musculus, Rattus norvegicus | S221 | YSALGSQRDKR | 1 | Homo sapiens | S271 | VVLAKSYNEQR | 1 | Homo sapiens | S271 | VALAKSFNEER | 1 | Mus musculus | S271 | VTLVKSFNEER | 1 | Rattus norvegicus | S3 | | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | S308 | LHYFNSDSFAS | 1 | Homo sapiens | S308 | LRYFPADMFKA | 1 | Mus musculus | S308 | LRYFPANMFKA | 1 | Rattus norvegicus | S310 | YFNSDSFASHP | 1 | Homo sapiens | S310 | YFPADMFKAHP | 1 | Mus musculus | S310 | YFPANMFKAHP | 1 | Rattus norvegicus | T23 | VLGFGTYATEE | 2 | Mus musculus, Rattus norvegicus | T23 | VLGFGTYAPPE | 1 | Homo sapiens | V137 | DENGKVIFDIV | 1 | Homo sapiens | V137 | DEHGNLIFDTV | 1 | Mus musculus | V137 | DEHGNLILDTV | 1 | Rattus norvegicus | V18 | GHSIPVLGFGT | 2 | Mus musculus, Rattus norvegicus | V18 | GHFMPVLGFGT | 1 | Homo sapiens | V265 | QLQRGVVVLAK | 1 | Homo sapiens | V265 | QLDRGIVALAK | 1 | Mus musculus | V265 | QLERGIVTLVK | 1 | Rattus norvegicus | V8 | SKHQCVKLNDG | 1 | Homo sapiens | V8 | SKIQKIELNDG | 1 | Mus musculus | V8 | SKIQKMELNDG | 1 | Rattus norvegicus | W227 | QRYKYCINEDT | 2 | Mus musculus, Rattus norvegicus | W227 | QRDKRWVDPNS | 1 | Homo sapiens | W86 | YTSKLWSTSHR | 2 | Mus musculus, Rattus norvegicus | W86 | YTSKLWSTFHR | 1 | Homo sapiens | Y216 | IVLVAYGALGT | 2 | Mus musculus, Rattus norvegicus | Y216 | IVLVAYSALGS | 1 | Homo sapiens | Y24 | LGFGTYAPPEV | 1 | Homo sapiens | Y24 | LGFGTYATEEH | 1 | Mus musculus | Y24 | LGFGTYATEEN | 1 | Rattus norvegicus | Y272 | VLAKSYNEQRI | 1 | Homo sapiens | Y272 | ALAKSFNEERI | 1 | Mus musculus | Y272 | TLVKSFNEERI | 1 | Rattus norvegicus | Y305 | DRNLHYFNSDS | 1 | Homo sapiens | Y305 | DRNLRYFPADM | 1 | Mus musculus | Y305 | DRNLRYFPANM | 1 | Rattus norvegicus | Y317 | ASHPNYPYSDE | 1 | Homo sapiens | Y317 | KAHPNFPFFDE | 1 | Mus musculus | Y317 | KAHPNFPFSDE | 1 | Rattus norvegicus | Y319 | HPNYPYSDEY | 1 | Homo sapiens | Y319 | HPNFPFFDEY | 1 | Mus musculus | Y319 | HPNFPFSDEY | 1 | Rattus norvegicus | Y55 | DCSHLYQNEEE | 2 | Mus musculus, Rattus norvegicus | Y55 | DSAHLYNNEEQ | 1 | Homo sapiens |